Introduction
============

It has been widely established that the actin-binding protein dystrophin is critical for muscle membrane cytoskeletal integrity. Loss-of-function mutations in dystrophin results in the X-linked catastrophic muscle-wasting disorder Duchenne's muscle dystrophy (DMD). Dystrophin is localized to the sarcolemma in skeletal muscles, where it associates with multiple transmembrane proteins, which include dystroglycan, to form the large membrane-spanning specialized adhesion complex known as the dystrophin protein complex (DPC; [@bib48]; [@bib60]; [@bib106]; [@bib27]; [@bib52]). Dystrophin binds F-actin inside the cell. Through extracellular interactions with laminin by dystroglycan, the DPC connects the muscle actin cytoskeleton to the ECM and, as such, is hypothesized to provide mechanical protection against the physical stresses of repetitive muscle contractions. Interruption of this linkage results in impaired membrane integrity and degeneration of muscle tissue ([@bib78]; [@bib22]; [@bib26]). Mutations in other DPC components, such as the sarcoglycans, also result in progressive muscle dystrophies, highlighting the importance of the DPC in maintaining muscle membrane integrity ([@bib91]). Interestingly, a significant number of DMD patients also exhibit cognitive deficits, the underlying pathology of which is not clear ([@bib15]; [@bib73]; [@bib101]). The prevalence of neural defects accompanying many dystrophin mutations suggests a wider role for dystrophin in humans, thus underscoring the importance of identifying their functions in the nervous system.

Like muscles, the nervous system is also subjected to mechanical forces exerted externally as well as within the organism itself. Neuronal circuitries established during development must withstand the physical stresses of brain growth and synaptic activity-dependent neuronal remodeling as well as the mechanical impacts of body movements and environmental insults ([@bib9]). Adhesion protein complexes are known to participate in maintaining neural integrity against these physical forces. For example, impaired N-cadherin function causes defects in maintaining the positions of neurons in zebrafish ([@bib62]; [@bib71]). The identification of molecules that participate in maintaining neural architecture has been relatively successful in *Caenorhabditis elegans* because of the simplicity of its nervous system and the ease of performing genetic manipulations. One protein that is required to maintain the *C. elegans* neural organization is SAX-7, a homologue of the L1 family of cell adhesion molecules (CAMs; [@bib9]; [@bib19]).

Vertebrate L1CAMs, which include L1, neuronal CAM (NrCAM), neurofascin, and CHL1, are known to function in nervous system development and function ([@bib50]). Mutations in human NrCAM can result in autism, whereas impaired L1 function causes several different X-linked neural disorders, which include corpus callosum hyperplasia, mental retardation, adducted thumbs, spastic paraplegia, and hydrocephalus ([@bib89]; [@bib97]; [@bib55]; [@bib31]; [@bib70]). As transmembrane proteins, L1CAMs have been shown to form cell--cell and cell--ECM adhesion via diverse extracellular interactions as well as associate with the membrane actin cytoskeleton by binding cytoskeletal linkers, such as ankyrin. This cytoskeletal anchorage via ankyrin has been shown to be important for L1CAM function ([@bib83]; [@bib16]). Ankyrin interaction is similarly important for SAX-7 function ([@bib105]). Additional binding sites to cytoskeletal linkers that are conserved in L1CAM cytoplasmic tails also contribute to SAX-7 function, underscoring the importance of cytoskeletal anchorage to L1CAMs. One of these sites, a PDZ (PSD95, Dlg, Zo1)-binding (PB) motif, was shown to mediate interaction with STN-2/γ-syntrophin ([@bib105]), a putative component of the DPC. This finding raises the possibility for dystrophin to function in conjunction with L1CAMs in the nervous system.

In this study, we present genetic data that the sole *C. elegans* dystrophin gene, *dys-1*, plays a role in maintaining neural organization. This novel role, which requires *dys-1* function in neurons, is distinguishable from its requirement in body-wall muscle to maintain muscle integrity and regulate membrane excitability for proper locomotion ([@bib10]; [@bib37]). We provide biochemical data that SAX-7 associates with DYS-1/dystrophin in an STN-2/γ-syntrophin--dependent fashion. Linkage to DYS-1/dystrophin likely provides SAX-7 anchorage to the actin cytoskeleton, thereby regulating SAX-7--mediated cell adhesions. This study provides insight into the common molecular mechanisms that may underlie diverse cognitive conditions, particularly those of the DMD and L1CAM disorders.

Results
=======

*dys-1* participates in positional maintenance of neurons
---------------------------------------------------------

We previously identified STN-2/γ-syntrophin as a SAX-7 interactor that regulates SAX-7 activity in maintaining placement of neurons and their axons ([@bib105]). Although the role of STN-2/γ-syntrophin has not been characterized, mammalian syntrophins are known components of the DPC that link diverse cytoplasmic and membrane proteins, including signaling proteins as well as water and sodium channels, to the DPC ([@bib13]; [@bib44]; [@bib66]; [@bib1]; [@bib33]; [@bib47]). Consistent with STN-2/γ-syntrophin functioning together with DYS-1/dystrophin, *stn-2(tm1869)* mutant animals exhibit similar abnormal movements with exaggerated head bending ([Fig. 1](#fig1){ref-type="fig"}), which was previously described for *dys-1* mutant animals ([@bib10]). Indeed, *dys-1* and *stn-2* mutant animals show the characteristic head bend ([Fig. 1 A](#fig1){ref-type="fig"}), and they move with a reduced number of body bends per minute as compared with wild-type animals ([Fig. 1 B](#fig1){ref-type="fig"}). As a putative DPC component, we hypothesized that STN-2/γ-syntrophin may link SAX-7 to the DPC and that this association may be important for SAX-7 function. To test this hypothesis, we assayed whether DYS-1/dystrophin participates in the positional maintenance of neurons (see Materials and methods). Analysis of *dys-1* mutant animals revealed displaced cholinergic neurons in \>20% of *dys-1(cx18)* and *dys-1(cx40)* adult animals ([Fig. 2](#fig2){ref-type="fig"}). Displacement of the affected neurons, which are embryonically derived ([@bib93]), is less prevalent in younger *dys-1* animals and is first detected in a small proportion of L3-staged larvae and an increasing proportion of L4-staged larvae ([Fig. 2 C](#fig2){ref-type="fig"}). This apparent progressive displacement is similarly observed in *sax-7* mutant animals ([@bib100]) and is consistent with a role for *dys-1* in maintaining the position of neurons.

![***dys-1* and *stn-2* are required in body-wall muscles, but not neurons, to regulate locomotion behavior.** (A) Quantification of young adult animals that exhibit exaggerated head bending during locomotion. Two sample sets were analyzed for wild type (WT), *dys-1*, and *stn-2,* in which *n* = 50 for each set. This phenotype is suppressed in *dys-1* and *stn-2* animals when the respective gene is expressed in the muscle (driven by the *myo-3* promoter) but not in neurons (driven by the *unc-119* promoter). Three independent transgenic lines were analyzed for each construct. The error bar of each transgenic line shows the standard error of the proportions of four sample sets in which *n* = 50 in each set. (B) Quantification of body bends per minute for the different strains (see Materials and methods). Three independent transgenic lines were analyzed for each construct. The error bars show the standard error of proportions of four sample sets in which *n* = 15 in each sample set. Statistical significance was assessed by Student's *t* test as compared with wild-type animals.](JCB_201006109_GS_Fig1){#fig1}

![**Mutations in *dys-1* cause defects in maintaining neuronal positions.** (A and B) Schematics and corresponding micrographs of VNC cholinergic neurons, as visualized in a young adult wild-type (WT) and *dys-1(cx18)* animal expressing the *Punc-129::gfp* marker (A) and VNC GABA neurons, as visualized in a young adult wild-type and a *dys-1(cx18)/+*;*sax-7(eq1)/+* animal expressing UNC-47::GFP (B). The brackets in A mark the vulval muscles, which also express *unc-129::gfp*. The green dots and lines represent the neuronal cell bodies and axonal processes, respectively. (C--E) The cholinergic neurons DB5, DA5, and DB6 and GABA neurons VD11, VD12, DD6, and VD13 are stereotypically positioned in wild-type animals (see Materials and methods; [Fig. S4](http://www.jcb.org/cgi/content/full/jcb.201006109/DC1)). The relative positions of the cholinergic neurons are altered in \>20% *dys-1* adult animals, a phenotype that is less prevalent in *dys-1* larvae (C), suggesting a positional maintenance role for *dys-1*. The quantification of young adult animals exhibiting displaced cholinergic (D) and GABA (E) neurons in *dys-1* and *sax-7* mutant backgrounds reveals a genetic interaction between *dys-1* and *sax-7*. Error bars show the standard error of the proportions of three sample sets in which *n* = 100 in each set. The p-values in C--E show the statistical significance as assessed by the Z test between the indicated strains. Bars, 10 µm.](JCB_201006109_RGB_Fig2){#fig2}

To further investigate a role for *dys-1* in neuronal position maintenance, we assessed whether *dys-1(cx18)* or *dys-1*(*cx40)* genetically interacts with *sax-7*. Genetic or pharmacological suppression of movements in *sax-7* animals was previously shown to suppress the neuronal displacement phenotype ([@bib92]; [@bib87]). Thus, in these genetic assays, we intentionally used *dys-1/+* heterozygosity to circumvent the possibility that the prolonged muscle excitation displayed by *dys-1* homozygous animals ([@bib10]; [@bib56], [@bib57]) may nonspecifically enhance neuronal displacement in *sax-7* mutant backgrounds. Moreover, because homozygous *sax-7(eq1)*-null animals exhibit \>95% penetrance of displaced neurons ([Fig. 2, D and E](#fig2){ref-type="fig"}; [@bib100]), we assessed the consequences of *dys-1/+* heterozygosity on neuronal displacement in *sax-7(eq1)/+* animals. Displaced cholinergic and γ-aminobutyric acid (GABA) neurons located along the ventral nerve cord (VNC) were observed in 10% *dys-1/+*;*sax-7(eq1)/+* trans-heterozygous animals, whereas neuronal displacement was not detected in either *dys-1/+* or *sax-7(eq1)/+* single heterozygous mutant animals ([Fig. 2, D and E](#fig2){ref-type="fig"}). This genetic interaction between *dys-1* and *sax-7* is significant and is also illustrated by an enhancement of displaced neurons by *dys-1/+* in animals that are homozygous for the hypomorphic *sax-7* allele *eq2* ([@bib100]). Indeed, displaced cholinergic neurons were detected in 37% of *dys-1/+*;*sax-7(eq2)* as compared with 4% of *sax-7(eq2)* single mutant animals ([Fig. 2 D](#fig2){ref-type="fig"}). The penetrance of GABA neuron displacement is also increased in *dys-1/+*;*sax-7(eq2)* animals as compared with *sax-7(eq2)* single mutant animals ([Fig. 2 E](#fig2){ref-type="fig"}). Collectively, these results reveal a role for *dys-1* in maintaining neuron positions.

Aging *dys-1* animals are reported to exhibit some muscle degeneration, particularly in a sensitized *hlh-1* mutant background ([@bib37]; [@bib40]). Thus, it is possible that *dys-1/+* in a sensitized *sax-7* background could result in muscle degeneration or abnormal muscle morphology, which may indirectly cause altered positioning of the adjacent VNC neurons and tissues along the ventral midline. Immunostaining of β-integrin and phalloidin staining of actin did not reveal the presence of muscle degeneration or obvious defects in muscle morphology and sarcomeric organization in young adult *dys-1* or *sax-7* animals or in *dys-1/+* animals in *sax-7* mutant backgrounds ([Fig. S1](http://www.jcb.org/cgi/content/full/jcb.201006109/DC1)). Furthermore, young adult *dys-1* or *sax-7* animals do not exhibit vulval displacement ([Fig. S2](http://www.jcb.org/cgi/content/full/jcb.201006109/DC1)), suggesting that this positional maintenance role for *dys-1* and *sax-7* is specific for neurons.

*dys-1* and *stn-2* are required in neurons, but not body-wall muscles, to maintain neuronal positioning
--------------------------------------------------------------------------------------------------------

We previously showed that *sax-7* is required in neurons as well as the adjacent hypodermis and body-wall muscles for positional maintenance of the VNC cholinergic and GABA neurons ([@bib100]). *dys-1* is predominantly expressed in the VNC neurons as well as body-wall and vulval muscles, as determined by *P~dys-1~*::*gfp* transcriptional reporters ([@bib10]; [@bib25]; [@bib51]). To determine the site of function for *dys-1*, we assayed for rescue of the displaced neuron phenotype in *dys-1* animals expressing full-length DYS-1/dystrophin in either neurons or muscles using tissue-specific promoters. Only DYS-1/dystrophin expressed in neurons rescued the neuronal displacement phenotype in *dys-1* homozygous and *dys-1/+*;*sax-7/+* animals ([Fig. 3](#fig3){ref-type="fig"}). Similarly, only neuronally expressed DYS-1/dystrophin suppressed the genetic enhancement displayed in *dys-1/+*;*sax-7(eq2)* animals, whereas DYS-1/dystrophin expressed in body-wall muscles did not ([Fig. 3](#fig3){ref-type="fig"}).

![***dys-1* is required in neurons, but not muscle, to maintain neuronal position.** (A and B) Tissue-specific expression assays reveal that *dys-1* functions in neurons, but not body-wall muscles, to maintain the position of cholinergic (A) and GABA (B) neurons. Neuronal and muscle expressions of *dys-1* were driven by the *unc-119* and *myo-3* promoters, respectively. Three independent transgenic lines were analyzed for each construct. The error bars show the standard error of the proportions of three sample sets in which *n* = 100 in each set. Statistical significance was assessed by the Z test. WT, wild type.](JCB_201006109_GS_Fig3){#fig3}

DYS-1/dystrophin expressed in body-wall muscles did, however, rescue the abnormal movement and head-bending phenotype, which is characteristic of *dys-1* animals ([Fig. 1](#fig1){ref-type="fig"}), indicating that the expressed DYS-1/dystrophin in muscles is functional. In fact, transgenic *dys-1* animals that expressed DYS-1/dystrophin in body-wall muscles are indistinguishable from wild-type animals, exhibiting no obvious phenotype other than displaced neurons. In contrast, *dys-1* animals expressing DYS-1/dystrophin in neurons still displayed the characteristic locomotory and head-bending phenotype ([Fig. 1](#fig1){ref-type="fig"}). This result is consistent with a previous study that revealed a requirement for DYS-1 in muscles, but not in neurons, for wild-type movements ([@bib10]). Thus, *dys-1* has two separable roles; i.e.,*dys-1* functions in neurons to maintain neuronal positioning and acts in body-wall muscles to control locomotory behavior.

*stn-2* is also expressed in VNC motor neurons and body-wall muscles ([@bib105]). Because *dys-1* is required only in neurons to maintain neuronal positioning, we anticipated that *stn-2* would also be required in neurons, but not muscles, for this function. Indeed, neuronal expression of STN-2/γ-syntrophin rescues the displaced VNC cholinergic and GABA neurons in *stn-2/+* animals in either *sax-7(eq1)/+* or a homozygous *sax-7(eq2)* sensitized background ([Fig. 4](#fig4){ref-type="fig"}). In contrast, muscle expression of STN-2/γ-syntrophin failed to rescue the neuronal displacement ([Fig. 4](#fig4){ref-type="fig"}). Like *dys-1*, expression of STN-2/γ-syntrophin in muscles, but not in neurons, rescues the abnormal locomotion and head bending exhibited by *stn-2* animals ([Fig. 1](#fig1){ref-type="fig"}). Similar to *dys-1*, both *stn-2* animals and *stn-2/+* animals in either a *sax-7(eq1)/+* or a homozygous *sax-7(eq2)* sensitized background do not exhibit muscle degeneration or obvious muscle abnormalities (Fig. S1), which may indirectly cause displacement of neurons. Thus, both *dys-1* and *stn-2* are required in neurons to maintain neuronal positioning, a function that is independent of their role in body-wall muscles.

![***stn-2* is required in neurons, but not muscle, to maintain neuronal position.** (A--D) Tissue-specific expression assays reveal that *stn-2* functions in neurons, but not body-wall muscles, to maintain the position of cholinergic (A and B) and GABA (C and D) neurons. Moreover, this function requires the STN-2 PDZ domain. Three independent transgenic lines were analyzed for each construct in which neuronal and muscle expressions of STN-2 were driven by the *unc-119* and *myo-3* promoters, respectively. The error bars show the standard error of the proportions of three sample sets in which *n* = 100 in each set. Statistical significance was assessed by the Z test. WT, wild type.](JCB_201006109_GS_Fig4){#fig4}

STN-2 interacts with DYS-1 by yeast two-hybrid (Y2H) assays
-----------------------------------------------------------

Vertebrate syntrophins, including γ-syntrophins, can bind dystrophins via their C-terminal syntrophin unique (SU) region ([@bib2]; [@bib3]; [@bib18]). The 62--amino acid SU region of STN-2 shares 55 and 62% similarity with the SU region of human γ1- and γ2-syntrophin, respectively. This conservation of the SU region in STN-2 indicates a possible interaction between STN-2 and DYS-1.

To investigate whether STN-2 interacts with DYS-1, a Y2H assay was performed. In this assay, rather than using full-length DYS-1, which is predicted to be a 417-kD protein, we tested the DYS-1 C-terminal end, which contains homologous sequences to mammalian dystrophins that are required for interacting with syntrophins ([@bib10]; [@bib35]). Yeast transformed with the full-length *stn-2* and C-terminal *dys-1* clones showed robust cell growth on the L/T/H and L/T/H/A selective media, indicating a positive interaction between STN-2 and DYS-1 ([Fig. 5 A](#fig5){ref-type="fig"}). An interaction between STN-1/αβ-syntrophin and DYS-1 was assessed as a negative control. As expected, STN-1/αβ-syntrophin and DYS-1 did not interact ([Fig. 5 B](#fig5){ref-type="fig"}), which was similar to results of a previous Y2H assay ([@bib40]). We also did not observe an interaction between STN-2 and the dystrophin-like molecule DYB-1/dystrobrevin ([Fig. 5 C](#fig5){ref-type="fig"}). To determine that the negative controls STN-1 and DYB-1 were expressed and functional in the Y2H assays, a known interaction between them ([@bib40]) was tested, which was positive as expected ([Fig. 5 D](#fig5){ref-type="fig"}). These negative controls underscore the specificity of the interaction between STN-2 and DYS-1. Thus, the two *C. elegans* syntrophins differentially interact with the dystrophin family of proteins; STN-2/γ-syntrophin interacts specifically with DYS-1/dystrophin, whereas STN-1/αβ-syntrophin interacts with DYB-1/dystrobrevin. Consistent with these molecular interactions, STN-1/αβ-syntrophin and DYB-1/dystrobrevin do not participate in neuronal positional maintenance ([Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201006109/DC1); [@bib105]).

![**STN-2, but not STN-1, molecularly interacts with DYS-1, as determined by Y2H assays.** The prey is comprised of full-length STN-2 or STN-1, whereas the bait is comprised of the C terminus of DYS-1 (amino acid residues 3,402--3,674) or full-length DYB-1. Cell growth on L/T selective media shows yeast cells that are successfully transformed with both the prey and bait constructs. Cell growth on L/T/H or L/T/H/A selective media reveals positive interactions between STN-2 and DYS-1 and between STN-1 and DYB-1.](JCB_201006109_GS_Fig5){#fig5}

STN-2 acts as an adaptor to link SAX-7 to the DYS-1 cytoskeleton
----------------------------------------------------------------

STN-2/γ-syntrophin can interact with both SAX-7 ([@bib105]) and DYS-1/dystrophin ([Fig. 5 A](#fig5){ref-type="fig"}), which was consistent with our hypothesis that STN-2/γ-syntrophin couples SAX-7 to DYS-1/dystrophin. To further test this hypothesis, we performed a protein recruitment assay using cultured cells, which was previously used to evaluate interactions between ankyrin and L1CAMs ([@bib104]; [@bib20]; [@bib105]). FLAG::STN-2 is primarily localized in the cytoplasm when expressed in HEK293 cells ([Fig. 6 A](#fig6){ref-type="fig"}). However, cotransfection with a SAX-7 construct, which is composed of rat neurofascin extracellular and transmembrane domains fused to the SAX-7 cytoplasmic tail (SAX-7CT), results in the redistribution of STN-2 to the cell cortex where the neurofascin::SAX-7 chimera is localized ([Fig. 6 B](#fig6){ref-type="fig"}). This result is consistent with the previously described interaction of STN-2/γ-syntrophin with the SAX-7CT ([@bib105]). If STN-2/γ-syntrophin functions as an adaptor to link SAX-7 to DYS-1/dystrophin, SAX-7 should similarly recruit DYS-1/dystrophin to the cell cortex in an STN-2/γ-syntrophin--dependent manner. To test this prediction, HEK293T cells were transfected with *dys-1*::*myc* and *neurofascin*::*sax-7* clones. As with the Y2H assay, the *dys-1*::*myc* clone encodes only the DYS-1 C-terminal region, which carries the syntrophin-interacting domain. DYS-1::Myc is cytoplasmic and does not colocalize with neurofascin::SAX-7 at the plasma membrane ([Fig. 6 C](#fig6){ref-type="fig"}). However, when FLAG::STN-2 is coexpressed together with DYS-1::Myc and neurofascin::SAX-7, DYS-1::Myc is largely redistributed from the cytoplasm to the cell cortex ([Fig. 6 D](#fig6){ref-type="fig"}). These results strongly suggest that DYS-1/dystrophin associates with SAX-7 only when STN-2/γ-syntrophin is present.

![**Protein recruitment assays in HEK293 cells suggest that SAX-7 associates with DYS-1 only in the presence of STN-2.** (A) FLAG::STN-2 is primarily localized in the cytoplasm, as detected by immunostaining with an anti-FLAG antibody. (B) Cotransfection with neurofascin::SAX-7CT (labeled SAX-7) causes FLAG::STN-2 to be redistributed to the cell cortex where SAX-7 is localized. (C) DYS-1::Myc, which contains the DYS-1 C-terminal amino acid residues 3,402--3,674, is primarily localized in the cytoplasm, as detected by anti-Myc antibody in cells transfected with both DYS-1::Myc and neurofascin::SAX-7CT. (D) When STN-2 is cotransfected, DYS-1::Myc is redistributed to the cell cortex where SAX-7 is localized, thus suggesting that SAX-7 can associate with DYS-1 via STN-2. Bar, 15 µm.](JCB_201006109_RGB_Fig6){#fig6}

To further confirm that DYS-1/dystrophin and STN-2/γ-syntrophin form a complex with SAX-7, the biochemical interactions of the three proteins were tested in HEK293T cells via coimmunoprecipitation (IP \[co-IP\]) assays. Neurofascin::SAX-7 was detected in anti-FLAG IPs of HEK293T cell lysates containing FLAG::STN-2 and neurofascin::SAX-7 ([Fig. 7, A](#fig7){ref-type="fig"} \[lane 2\] and B \[lane 1\]). In contrast, neurofascin::SAX-7 was not detected in anti-FLAG IPs on cell lysates containing FLAG::STN-1 and neurofascin::SAX-7 ([Fig. 7 A](#fig7){ref-type="fig"}, lane 5) or FLAG::STN-2 and neurofascin::SAX-7CT lacking the PB sequence ([Fig. 7 A](#fig7){ref-type="fig"}, lane 4). These results were expected based on our previous results that STN-2/γ-syntrophin, but not STN-1/αβ-syntrophin, interacts with SAX-7 via the PB domain ([@bib105]). Neurofascin::SAX-7 was also not detected in IPs of cell lysates containing a mutated FLAG::STN-2 that lacks the PDZ domain (STN-2::ΔPDZ) and neurofascin::SAX-7 ([Fig. 7 B](#fig7){ref-type="fig"}, lane 2), suggesting that the PDZ domain is required for STN-2/γ-syntrophin to interact with SAX-7. The importance of the STN-2 PDZ domain is underscored by the result that expression of STN-2::ΔPDZ cannot rescue the neuronal displacement phenotype in *sax-7(eq1)/+*;*stn-2/+* animals or suppress the phenotypic enhancement in *sax-7(eq2)*/*sax-7(eq2)*;*stn-2/+* animals ([Fig. 4](#fig4){ref-type="fig"}).

![**STN-2 acts as a linker protein that bridges SAX-7 to DYS-1, as determined by co-IP assays in HEK293 cells.** (A and B) Neurofascin::SAX-7CT (labeled SAX-7) interacts with STN-2, as shown in A (lane 2) and B (lane 1). This interaction depends on the SAX-7 PB sequence (A, lane 4) and the STN-2 PDZ domain (B, lane 2). This interaction between SAX-7 and STN-2 is specific because SAX-7 does not interact with STN-1 (A, lane 5). (C and D) The C-terminal end of DYS-1 (amino acid residues 3,402--3,674) interacts with STN-2, but not STN-1, as DYS-1 coimmunoprecipitates with STN-2 (C, lane 2) but not with STN-1 (C, lane 4). The reverse IP shows that STN-2 (D, lane 2), but not STN-1 (D, lane 4), coimmunoprecipitates with DYS-1. (E and F) Although SAX-7 does not coimmunoprecipitate with DYS-1 (E, lane 2; and F, lane 3), SAX-7 does so when STN-2 is present (E, lane 1; and F, lane 1), suggesting this tripartite complex requires STN-2 as a linking molecule. Co-IP of SAX-7 with STN-2 and DYS-1 requires the PB sequence of SAX-7 (E, lane 3) and the PDZ domain of STN-2 (F, lane 2).](JCB_201006109_RGB_Fig7){#fig7}

The interaction between STN-2/γ-syntrophin and DYS-1/dystrophin was tested next. Reciprocal co-IPs were observed with FLAG::STN-2 and DYS-1::Myc ([Fig. 7, C and D](#fig7){ref-type="fig"}, lane 2) but not with FLAG::STN-1 and DYS-1::Myc ([Fig. 7, C and D](#fig7){ref-type="fig"}, lane 4). It is interesting that both our Y2H and co-IP experiments, as well as an independent Y2H assay ([@bib40]), consistently showed a lack of interaction between STN-1/αβ-syntrophin and the C-terminal end of DYS-1, whereas a previously published in vitro binding assay using a purified GST--STN-1 fusion protein suggested otherwise ([@bib35]). This difference may reflect dissimilar experimental approaches and conditions that could suggest a weak interaction between STN-1/αβ-syntrophin and DYS-1/dystrophin. For example, the intrinsic ability for GST to dimerize ([@bib99]; [@bib24]; [@bib65]) could have resulted in the oligomerization of the GST--STN-1 fusion protein that was used in the in vitro binding assay, which, in turn, may have enhanced a weak interaction between STN-1 and DYS-1. Similar oligomerization and influence of activity on diverse fusion proteins induced by GST have been reported ([@bib41]; [@bib75]; [@bib84]).

To investigate whether SAX-7 could interact with DYS-1/dystrophin, anti-Myc IPs were performed on cell lysates containing both DYS-1::Myc and neurofascin::SAX-7. Neurofascin::SAX-7 did not coimmunoprecipitate ([Fig. 7, E](#fig7){ref-type="fig"} \[lane 2\] and F \[lane 3\]), which was consistent with a lack of association between SAX-7 and DYS-1/dystrophin, as suggested in the protein recruitment assay. However, in anti-Myc IPs on lysates of cells in which FLAG::STN-2 was cotransfected with both DYS-1::Myc and neurofascin::SAX-7CT, neurofascin::SAX-7CT coimmunoprecipitated along with FLAG::STN-2 ([Fig. 7, E and F](#fig7){ref-type="fig"}, lanes 1), which was consistent with SAX-7 being present in a complex with DYS-1 and STN-2. Collectively, these results strongly suggest a role for STN-2/γ-syntrophin as an adaptor protein that couples SAX-7 and DYS-1/dystrophin together in a protein complex.

Discussion
==========

This study uncovers a novel neuronal role for DYS-1/dystrophin in maintaining the structure and organization of the *C. elegans* nervous system in collaboration with the SAX-7/L1CAM. This role is distinct from its previously established muscle function in maintaining muscle integrity and regulating locomotion. The presented genetic and biochemical data provide evidence that SAX-7 is linked to DYS-1/dystrophin via STN-2/γ-syntrophin and that this tripartite protein complex is required in neurons ([Fig. 8](#fig8){ref-type="fig"}). Dystrophin and the associated actin cytoskeleton likely provide anchorage to SAX-7, thereby regulating SAX-7 activity in maintaining neuronal positions.

![**A model depicting how STN-2/γ-syntrophin may regulate SAX-7 activity in maintaining neuronal positions, as based on genetic and biochemical data.** The model speculates that STN-2/γ-syntrophin links SAX-7 to the DYS-1/dystrophin-based actin cytoskeleton in neurons but not muscles. This interaction is dependent on the STN-2 PDZ domain to interact with the SAX-7 PB motif and requires the STN-2 syntrophin unique (SU) domain to interact with the C-terminal end of DYS-1. DYS-1 is predicted to bind to the actin cytoskeleton by its N-terminal actin-binding domain. This linkage to the actin cytoskeleton may provide SAX-7 anchorage, thereby regulating SAX-7--mediated cell adhesion. Interruption of this anchorage leads to a defect in maintaining neuronal positions. UNC-44/ankyrin also interacts molecularly and genetically with SAX-7 ([@bib105]), but it is not known whether UNC-44/ankyrin is required in neurons and/or body-wall muscles; this unknown is depicted as "UNC-44?" in the schematic. Ig, Ig-like repeats; FNIII, fibronectin type III repeats; FB, FERM-binding sequence; and AB, ankyrin-binding sequence.](JCB_201006109_RGB_Fig8){#fig8}

A distinct neuronal DPC functions to maintain neural architecture
-----------------------------------------------------------------

Mutations in *dys-1* cause progressive muscle degeneration in sensitized genetic backgrounds ([@bib37]; [@bib69]), indicating a conserved role for dystrophin in maintaining muscle integrity. *dys-1* mutant animals also exhibit a distinctive movement phenotype (i.e., exaggerated bending of the head and anterior body and prolonged muscle contraction), which is shown, in part, to be caused by abnormal cholinergic transmission ([@bib10]; [@bib39]). This phenotype can be rescued by wild-type DYS-1 expressed in muscle but not neurons ([@bib10]). Mutations in genes encoding other components of the *C. elegans* DPC, such as *stn-2/*γ-syntrophin, *stn-1*/αβ-syntrophin, and *dyb-1*/dystrobrevin, also lead to locomotory phenotypes that are indistinguishable from that of *dys-1*, suggesting that these DPC components function in muscles for proper cholinergic transmission ([Fig. 1](#fig1){ref-type="fig"}; [@bib36], [@bib38]; [@bib40]; [@bib56]). Indeed, *stn-1* and *stn-2* expression in muscles, but not neurons, can rescue the locomotory phenotype in the respective mutant animals ([Fig. 1](#fig1){ref-type="fig"}; [@bib40]).

In addition to a role for the DPC in muscles, we identified a novel neuronal role of DYS-1/dystrophin and STN-2/γ-syntrophin in the positional maintenance of neurons, which is independent of their function in muscles. This neuronal role is not shared by STN-1/αβ-syntrophin or DYB-1/dystrobrevin (Fig. S3; [@bib105]), although both proteins are also extensively expressed in the nervous system ([@bib38]; [@bib40]). It is not known what function STN-1/αβ-syntrophin or DYB-1/dystrobrevin mediates in neurons or whether these roles involve DYS-1/dystrophin. Thus, at least in neurons, the DPCs are likely variable in composition and function.

It is not clear how neuronal displacement impacts neural functions in *dys-1* mutant animals or whether *dys-1* mediates additional functions in neurons other than maintaining neuronal positioning. Animals that lack *dys-1* in neurons (i.e.,*dys-1* mutant animals expressing *dys-1* only in muscles) have no obvious phenotype other than displaced neurons. Assays that assess behavior and higher order neural function (e.g., learning and memory) still need to be performed to address these questions.

STN-2/γ-syntrophin and DYS-1/dytrophin provide cytoskeletal anchorage to SAX-7
------------------------------------------------------------------------------

The protein recruitment assay and co-IP experiments suggest that STN-2/γ-syntrophin can act as an adaptor to link SAX-7 to DYS-1/dystrophin. As dystrophin is an actin-binding protein, the association of SAX-7 with DYS-1/dystrophin raises the possibility that SAX-7 is linked to the cortical actin cytoskeleton. Linkage of CAMs, including L1CAMs, cadherins, and integrins, to the cortical cytoskeleton has been shown to be required for robust cell adhesion ([@bib12]; [@bib82]; [@bib43]). Indeed, cultured cells expressing neurofascin that cannot bind ankyrin exhibit reduced cell--cell adhesion, presumably because of a poor association with the spectrin-based actin cytoskeleton ([@bib32]; [@bib95]). In *C. elegans*, UNC-44/ankyrin has been shown to function with SAX-7 in neuronal positional maintenance, which was consistent with the importance of linkage to the spectrin-actin cytoskeleton ([@bib105]). We thus speculate that STN-2/γ-syntrophin and DYS-1/dystrophin participate in neuronal positional maintenance by coupling SAX-7 to the cortical actin cytoskeleton. Interruption of this cytoskeleton linkage by either deletion of the SAX-7 PB sequence or the STN-2 PDZ domain or by knocking out *stn-2* or *dys-1* function leads to defects in maintaining neuronal position, probably caused by reduced SAX-7 activity in mediating cell adhesion.

It is thus puzzling that displaced cholinergic neurons are detected in *dys-1*, but not in *stn-2*, mutant animals. This difference suggests that DYS-1/dystrophin can also mediate SAX-7 function in an STN-2--independent fashion. Proteins that may compensate for the loss of STN-2/γ-syntrophin are not known, but one candidate protein may be UNC-44/ankyrin. A recent study uncovered the ability of mammalian ankyrins to bind dystrophin via a cysteine-rich domain, which is located close to, but distinct from, the syntrophin-interacting domain in the C terminus of dystrophin ([@bib7]). Interaction with dystrophin has been shown for ankyrin-G and ankyrin-B, which are required for the proper localization of dystrophin at the costameres and sarcolemma, respectively, in murine skeletal muscle ([@bib7]). Thus, UNC-44/ankyrin may compensate for the loss of STN-2 to couple SAX-7 to the dystrophin-based cytoskeleton, thus reflecting the lack of phenotype in *stn-2* mutant animals. This speculation would require that the regulation of SAX-7 activity by UNC-44/ankyrin occurs in neurons, which is currently not known.

The expression of UNC-44/ankyrin in neurons, body-wall muscles, and the hypodermis ([@bib20]) suggests that UNC-44/ankyrin could regulate SAX-7 activity in one or more of these tissues; SAX-7 is required in all three tissues to ensure that neural integrity is maintained ([@bib100]). Consistent with UNC-44/ankyrin acting as an adaptor to link SAX-7 to the spectrin-actin cytoskeleton, SPC-1/α-spectrin and UNC-70/β-spectrin are similarly expressed in multiple tissues, including neurons, body-wall muscles, and the hypodermis ([@bib42]; [@bib79]; [@bib85]). That SAX-7 may be coupled to both the dystrophin- and spectrin-based actin cytoskeletons raises the question of how cytoskeletal linkage of SAX-7 is coordinated. Are both the dystrophin- and spectrin-based cytoskeletons required in neurons for SAX-7 activity? Is SAX-7 associated with both cytoskeletons simultaneously, or are distinct subpopulations of SAX-7 linked to each cytoskeleton? If only the dystrophin-based cytoskeleton is required in neurons, how is linkage to the spectrin-based cytoskeleton prevented? In addition to the cortical actin cytoskeleton, dystrophin also binds intermediate filaments and microtubules ([@bib88]; [@bib63]). Thus, SAX-7 may be simultaneously anchored to one of these alternative cytoskeletons in addition to the spectrin-actin cytoskeleton.

Implications for mammalian L1CAMs
---------------------------------

Mammalian dystrophin and DPC components are also expressed in neurons ([@bib98]). In contrast to their functions in muscles, dystrophin and the DPC components in the mammalian nervous system have not been as extensively characterized. These neuronal DPC complexes apparently are molecularly heterogeneous ([@bib11]; [@bib98]), suggesting multiple neuronal roles for the DPC.

The importance of dystrophin in the brain is directly indicated by cognitive impairments and neuropsychiatric disorders (e.g., autism and schizophrenia) that can be presented in DMD patients ([@bib15]; [@bib5]). Autopsy studies on DMD patients revealed brain abnormalities that include disordered connections and architectural changes ([@bib90]; [@bib54]; [@bib80]; [@bib96]; [@bib58]). The *mdx* dystrophin mutant mice similarly exhibit an abnormal architecture of the brain that includes altered distribution of populations of neurons ([@bib17]; [@bib23]; [@bib77]). They also display altered spontaneous inhibitory postsynaptic currents in the cerebellar Purkinje cells, which may reflect the need for dystrophin to cluster GABA~A~ receptors in hippocampal pyramidal neurons and inhibitory synapses of cerebellar Purkinje cells ([@bib59]; [@bib6]; [@bib61]). Based on the role of *C. elegans* dystrophin in maintaining neural organization, impaired mammalian dystrophin may similarly affect neural integrity, thus accounting for some of the functional and architectural abnormalities present in the brains of DMD patients and *mdx* mice.

The association of DYS-1/dystrophin with SAX-7 via STN-2 suggests that mammalian L1CAMs could similarly function with dystrophin in the nervous system. Of the mammalian L1CAMs, NrCAM has a PB sequence (amino acids NSFV) that is most similar to that of SAX-7 (amino acids STFV). The similar expressions of NrCAM, γ-syntrophins, and dystrophin in the cerebral cortex, hippocampal pyramidal neurons, and the cerebellar cortex Purkinje cells of the mammalian brain are consistent with their ability to interact ([@bib64]; [@bib86]; [@bib49]; [@bib8]; [@bib4]; [@bib53]; [@bib46]; [@bib77]). Although it is not known whether NrCAM functions in a similar capacity as SAX-7 for proper neural organization, the importance of NrCAM in the brain is underscored by the impaired cognitive function and social behavior exhibited by NrCAM-null mice ([@bib81]). Moreover, mutations in human NrCAM can lead to autism ([@bib70]), a disorder that is also presented in significant numbers of DMD patients ([@bib102]; [@bib45]). The apparent overlap of neural symptoms of DMD and L1CAM disorders, together with our data that DYS-1/dystrophin and SAX-7 function in a complex, suggests the mammalian counterparts may act in a homologous fashion for proper neural architecture and nervous system function.

Materials and methods
=====================

Strains
-------

*C. elegans* strains, provided by the *Caenorhabditis* Genetics Center, were grown on nematode growth medium plates at 21°C as described by [@bib14]. N2 Bristol served as the wild-type strain. The alleles used in this study are listed by linkage groups as follows: LGI, *dys-1(cx18)*, *dys-1(cx40)* ([@bib10]), and *dyb-1(cx36)* ([@bib36]); LGIV, *sax-7(eq1)* ([@bib105]), and *sax-7(eq2)* ([@bib100]); and LGX and *stn-2(tm1869)* ([@bib105]).

*C. elegans* expression vectors and generation of transgenic animals
--------------------------------------------------------------------

Transgenic animals were generated according to standard procedures ([@bib74]). To generate *P~unc-119~::dys-1* (pLC587), a 9.0-kb *dys-1* genomic sequence from WRM0611bE10 (Geneservice) was pieced together at exon 30 with 3.9-kb *dys-1* cDNA and 169-bp *dys-1* 3′ untranslated region (obtained from yk1473g12 and yk1434h02; Y. Kohara, National Institute of Genetics, Mishima, Japan) and subcloned into the pBluescript II KS vector between NotI and XmaI. The pan-neuronal *unc-119* promoter ([@bib67], [@bib68]) was inserted at NotI to drive *dys-1* expression in neurons. The resulting construct was injected at 190 ng/µl along with 2 ng/µl of the coinjection marker *Pmyo-2*::*tdTomato* (a gift from S. Panowski and A. Dillin, Salk Institute, La Jolla, CA) into *dys-1(cx18)*.

To generate *P~myo-3~::dys-1* (pLC586), a pLC587 derivative replacing the *unc-119* promoter with the muscle-specific *myo-3* promoter ([@bib29]) was used to drive *dys-1* expression in muscles. 160 ng/µl of the resulting construct was injected into *dys-1(cx18)* along with 40 ng/µl of the coinjection marker *sur-5::dsRed* ([@bib103]).

To generate *P~stn-2~::stn-2::gfp* (pLC551), the *stn-2* promoter (3.82-kb sequences upstream of the start codon) and 1.5-kb *stn-2* cDNA (obtained from yk788e09; Y. Kohara) were placed in frame with *gfp* coding sequences and the *unc-54* 3′ untranslated region ([@bib28]), all of which were subcloned into the pBluescript II KS vector between NotI and ApaI. 50 ng/µl of the resulting construct was injected into *stn-2(tm1869)* animals along with 50 ng/µl of the coinjection marker *sur-5::dsRed* ([@bib103]).

To generate*P~unc-119~::stn-2::gfp* (pLC553), a pLC551 derivative with the *stn-2* promoter was replaced with the *unc-119* promoter. 50 ng/µl of this construct was injected into *stn-2(tm1869)* animals along with 70 ng/µl of the coinjection marker *P~str-1~::gfp* ([@bib94]).*P~unc-119~::stn-2::gfp::ΔPDZ* (pLC590) was generated from a pLC553 derivative lacking the STN-2 PDZ domain (amino acids 74--150), which was injected at 50 ng/µl into *stn-2(tm1869)* animals along with 70 ng/µl of the coinjection marker *P~str-1~::gfp* ([@bib94]).

*P~myo-3~::stn-2::gfp* (pLC554) was generated from a pLC553 derivative that replaced the *stn-2* promoter with the *myo-3* promoter. This construct was injected at 50 ng/µl into *stn-2(tm1869)* animals along with 70 ng/µl of the coinjection marker *P~str-1~::gfp* ([@bib94]).

Live animal microscopy---scoring for displaced neurons
------------------------------------------------------

The *oxIs12* (*unc-47::gfp*; [@bib72]) and *evIs78* (*P~unc-129~::gfp*; [@bib21]) integrated transgenes were crossed into respective strains to visualize GABA or cholinergic neurons, respectively. Synchronized young adult animals of all these strains as well as synchronized *dys-1* larvae of various stages were mounted on 2% agarose pads and scored for neuronal displacement with the 40× 1.3 NA Neofluar objective using a microscope (Axioplan 2 IE) with the image captured with a camera (AxioCam MRm) and imaging software (AxioVision 4.5; Carl Zeiss, Inc.).

Of the VNC cholinergic neurons, the relative positions of the DB5, DA5, and DB6 neurons are most consistently altered in the examined genetic strains as compared with wild type ([Fig. 2 A](#fig2){ref-type="fig"}) and, thus, were the focus of our analysis. The ratio of the distance between DB5 and DA5 (designated D1) to the distance between DA5 and DB6 (designated D2) was calculated ([Fig. S4 A](http://www.jcb.org/cgi/content/full/jcb.201006109/DC1)). D1 and D2 are similar in wild-type animals so that the mean D1/D2 ratio is slightly more than one (Fig. S4 B). Neurons are considered displaced when the D1/D2 ratio in an animal is two or greater, as a result of the D2 value being less than half that of D1 because DA5 and DB6 are closer to each other ([Fig. 2 A](#fig2){ref-type="fig"}).

Of the VNC GABA neurons, the relative positions of VD11, VD12, DD6, and VD13 neurons are most consistently altered in the examined genetic strains as compared with wild type ([Fig. 2 B](#fig2){ref-type="fig"}) and, thus, were the focus of our analysis. The ratio of the distance between VD11 and VD12 (designated D1) to the distance between VD12 and VD13 (designated D2) was calculated (Fig. S4 C). In wild-type animals, D1 is generally more than three times larger than D2 so that the mean D1/D2 ratio is 3.5 (Fig. S4 D). Neurons are considered displaced when the D1/D2 ratio in an animal is one or less, as a result of the D1 value being equal to or less than that of D2 because VD12 or DD6 is closer to VD11 ([Fig. 2 B](#fig2){ref-type="fig"}).

Live animal microscopy---determining vulval position
----------------------------------------------------

Synchronized L4 wild-type, *sax-7*, and *dys-1* animals were mounted on 2% agarose pads and were examined under a microscope (Axioplan 2 IE) to determine the position of the vulva relative to the pharynx and the anus. Based on the calculation PV/(PV + VA), in which PV is the distance between the base of the pharyngeal terminal bulb and the center of the vulva and VA is the distance between the center of the vulva and the anal opening (Fig. S3 A), the vulva in *sax-7* and *dys-1* animals appears to be positioned similarly to that of wild type (Fig. S3 B).

Locomotion assay
----------------

A single young adult animal (8--12 h after the L4 stage) was transferred to a nematode growth medium plate with a fresh lawn of OP50 *Escherichia coli*. After 10 s of recovery, the number of body bends was measured during a subsequent 1-min period. A body bend is defined as a period of one sinusoidal track left by the animal on the bacteria lawn. Only animals without backward movement in that 1-min period were quantified.

Immunofluorescence analysis
---------------------------

Animals were fixed in methanol and stained for indirect immunofluorescence using the freeze-crack methanol fixation method ([@bib76]). Rhodamine-conjugated phalloidin (1:25 concentration; Invitrogen) against polymerized actin, the MH25 monoclonal antibody (1:300 concentration) against β-integrin ([@bib30]; [@bib34]), and the Alexa Fluor 488 secondary antibody (1:500 concentration; Invitrogen) were used. Samples were examined with a 100× 1.45 NA PlanFLUAR objective (Carl Zeiss, Inc.) using a microscope (Axioplan 2 IE) with the image captured with a camera (AxioCam MRm) and imaging software (AxioVision 4.5).

Y2H constructs
--------------

All Y2H bait and prey constructs were generated by subcloning coding sequences of *stn-1*, *stn-2*, *dys-1*, and *dyb-1* into the respective vectors (Matchmaker GAL4 Two-Hybrid System 3; Takara Bio Inc.). The baits, pLC569 and pLC570, respectively contain *stn-1* and *stn-2* cDNA, which were subcloned into the pGBKT7 vector (Trp selective marker) in frame with the GAL4 DNA-binding domain. The preys, pLC571 and pLC572, respectively contain a *dys-1* cDNA fragment encoding amino acids 3,402--3,674 and *dyb-1* cDNA, which were subcloned into the pGADT7 vector (Leu selective marker) in frame with the GAL4 DNA-activating domain.

Y2H assays
----------

All yeast assays were performed in the AH109 yeast strain, which were cultured on the following synthetic defined (SD) minimal media lacking specified amino acids according to the manufacturer's instructions: SD/−Leu, SD/−Trp, SD/−Leu/−Trp, SD/−Leu/−Trp/−His + 2.5 mM 3-AT, SD/−Leu/−Trp/−His/−Ade + 12.5 mM 3-AT, SD/−Leu/−His + 2.5 mM 3-AT, and SD/−Trp/−His + 2.5 mM 3-AT (Takara Bio Inc.). 2.5 mM 3-AT was added to reduce the number of background colonies caused by leaky His expression. We confirmed that both bait and prey constructs (a) did not activate readout reporters on their own, e.g., grow on media lacking His or His/Ade, and (b) did not interact nonspecifically with the provided negative control pGADT7-T (for baits) or pGBKT7-lam (for preys). A positive interaction was considered robust if there were numerous large nonred (white) colonies growing on media lacking Leu/Trp/His/Ade. Positive interactions were further assayed by performing X-α- and β-galactosidase tests on these nonred colonies, which should turn strongly blue if there is robust interaction between bait and prey.

Mammalian cell expression vectors
---------------------------------

Mammalian cell expression vectors used in this study were neurofascin::SAX-7CT (pLC101; [@bib20]); neurofascin::SAX-7::ΔPB (pLC573), a pLC101 derivative lacking the PB motif STFV; *P~cmv~::FLAG::stn-1* (pLC565), the *stn-1* cDNA (obtained from yk109h11) that was subcloned into p3×FLAG-CMV-7.1 (Sigma-Aldrich) between NotI and KpnI; *P~cmv~::FLAG::stn-2* (pLC566), the *stn-2* cDNA that was subcloned into p3×FLAG-CMV-7.1 (Sigma-Aldrich) between SalI and BamHI; and *P~cmv~::FLAG::stn-2::ΔPDZ* (pLC588), a pLC566 derivative lacking the PDZ domain (amino acids 74--150). *P~cmv~::dys-1::Myc* (pLC574), a *dys-1* cDNA fragment encoding amino acids 3,402--3,674, was cloned into pcDNA3.1/Myc--His B (Invitrogen) between KpnI and BamHI.

Cell culture and transfection
-----------------------------

HEK293T cells were cultured in DME (Mediatech, Inc.) with 10% newborn bovine serum and treated with transfection reagent (Lipofectamine 2000; Invitrogen) according to the standard procedure provided by the manufacturer during DNA transfection. 40 h after transfection, cells were collected and washed with PBS in preparation for either immunofluorescence or co-IP assays.

Protein recruitment assay in HEK293 cells
-----------------------------------------

The assay was performed as previously described ([@bib104]). Cells were fixed with formaldehyde, washed, and incubated with anti-FLAG (M2; Sigma-Aldrich), anti-Myc (9E10; Covance), or anti-SAX-7 (6991; [@bib20]) antibodies to visualize FLAG::STN-2, DYS-1::Myc, or neurofascin::SAX-7CT, respectively. Images were acquired using Axioplan 2 IE, AxioCam MRm, and AxioVision 4.5.

Co-IP assays
------------

Cell lysates were prepared in NETN buffer containing 1 mM NaF, 2.5 mM β-glycerophosphate, and a protease inhibitor cocktail (Roche). 200--500 µl of cell lysate was incubated with NETN buffer (0.05-M Tris, pH 7.8, 0.1-M NaCl, 1 mM EDTA, and 0.5% NP-40) containing the FLAG or Myc antibody at 4°C for 1 h. Immune complexes were precipitated with 20 µl of protein A/G beads (Santa Cruz Biotechnology, Inc.) at 4°C for 4 h. The beads were washed three times with NETN lysis buffer, and then the immune complexes were eluted by heating the beads to 95°C for 5 min in SDS sample buffer containing DTT. Blots were probed as described in the next section.

Western blot analysis and reagents
----------------------------------

Cell lysates were prepared in NETN buffer containing 1 mM NaF, 2.5 mM β-glycerophosphate, and a protease inhibitor cocktail. Cell lysates were resolved by SDS-PAGE and electrophoretically transferred to the nitrocellulose membrane. Membranes were blocked in TBS-T (0.15-M NaCl, 20 mM Tris, pH 8, and 0.05% Tween 20) containing 5% bovine albumin (Sigma-Aldrich) for 1 h. Blots were probed with primary antibodies followed by horseradish peroxidase--conjugated anti--mouse (Mouse TrueBlot Ulture; eBioscience) or anti--rabbit secondary antibody (Jackson ImmunoResearch Laboratories, Inc.). Blots were then developed on film using an enhanced chemiluminescence kit (Thermo Fisher Scientific) according to the manufacturer's instructions. The primary antibodies used in this study included anti-FLAG (M2; Sigma-Aldrich), anti-Myc (9E10; Covance), and anti--SAX-7 (6991; [@bib20]).

Online supplemental material
----------------------------

Fig. S1 shows that immunofluorescence experiments reveal normal body-wall muscles in animals of *sax-7*, *stn-2*, or *dys-1* genetic backgrounds. Fig. S2 shows that the relative position of the vulva is normal in *sax-7* and *dys-1* animals. Fig. S3 demonstrates that *dyb-1* mutant animals do not display neuronal position defects. Fig. S4 shows the positions of cholinergic and GABAergic neurons in wild-type animals. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201006109/DC1>.
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